Literature DB >> 2875701

Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'.

D F Levinson, G M Simpson.   

Abstract

From 39 reported cases of the "neuroleptic malignant syndrome," three groups were identified: those with concurrent medical problems that could cause fever that accompanied the extrapyramidal symptoms; those with medical problems less clearly related to fever; and those without other medical disorders. Dehydration, infection, pulmonary embolus, and rhabdomyolysis were the common complications of untreated extrapyramidal symptoms. Three patients died, all with medical complications. In 14 cases, no medical cause of fever was identified. Hypotheses about mechanisms for fever include psychiatric illness, disruption of dopaminergic aspects of thermoregulation, and peripheral and central effects on muscle contraction leading to excess heat production. Neuroleptic-induced rigidity should be treated vigorously, with prompt discontinuation of neuroleptic therapy and administration of dopamine agonists in severe cases with or without fever. The cases of extrapyramidal symptoms with fever are too heterogeneous to justify the assumption of a unitary and "malignant" syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875701     DOI: 10.1001/archpsyc.1986.01800090025005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  18 in total

1.  Neuroleptic malignant syndrome without rigidity.

Authors:  F Benazzi
Journal:  Ital J Neurol Sci       Date:  1991-02

2.  Misconceptions and inappropriate use of terms in hyperthermic syndromes.

Authors:  B J Van Hilten; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

3.  [An interdisciplinary unit for major psychiatric/somatic comorbidity: concept and 22 years of experience].

Authors:  F Lederbogen; D Kopf; W Hewer
Journal:  Nervenarzt       Date:  2008-09       Impact factor: 1.214

4.  Neuroleptic malignant syndrome with metoclopramide overdose coexisting with Clostridium difficile diarrhea.

Authors:  Azhar Supariwala; Gunjan Kant; Raymonde E Jean
Journal:  Intensive Care Med       Date:  2011-06-18       Impact factor: 17.440

5.  Haloperidol-induced neuroleptic malignant syndrome in a 67-year-old woman with parkinsonism.

Authors:  T C Ryken; A N Merrell
Journal:  West J Med       Date:  1989-09

6.  Neuroleptic malignant syndrome.

Authors:  T H Lee; L M Tang
Journal:  J Neurol       Date:  1988-05       Impact factor: 4.849

7.  Neuroleptic malignant syndrome: nine cases.

Authors:  A Freyne; A McCarthy
Journal:  Ir J Med Sci       Date:  1988-10       Impact factor: 1.568

8.  Neuroleptic malignant syndrome: a complication of neuroleptics and cocaine abuse.

Authors:  M J Akpaffiong; P Ruiz
Journal:  Psychiatr Q       Date:  1991

Review 9.  Neuroleptic malignant syndrome.

Authors:  P F Buckley; M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

Review 10.  The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity.

Authors:  M V Balzan
Journal:  Postgrad Med J       Date:  1998-02       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.